Weaver Consulting Group’s Moderna MRNA Stock Holding History

Weaver Consulting Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$236K	Buy
2020 Q4	–	Sell
2020 Q3	$51K	Sell
2020 Q2	$48K	Buy